Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats

Fig. 2

Expression of genes involved in fatty acid and lipid absorption in the intestine. (a) Experimental protocol. Pemafibrate or vehicle was administered with olive oil to rats for 7 days, and then the rats were dissected. (b) The mRNA level of Ppara. N = 4 per group; *P < 0.05. (c-h) The mRNA levels of genes related to the transport of long-chain fatty acids and lipids, c; cluster of differentiation (Cd36), d; microsomal triglyceride transfer protein (Mtp) and fatty acid-binding protein (Fabp), including e; liver FABP (Fabp1) and f; intestinal FABP (Fabp2), g; fatty acid transporter protein 4 (Fatp4), and h; apolipoprotein A-IV (Apoa-IV). N = 4 per group; *P < 0.05. Data in the bar plots are expressed as mean ± standard deviation. Significant differences were determined using the Mann–Whitney U-test

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us